Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study

BACKGROUND: Based on a large, representative unscreened cohort from Malmö, Sweden, we have recently reported that a single prostate-specific antigen (PSA) measurement at or before age 50 is a strong predictor of prostate cancer occurring up to 25 years subsequently. We aimed to determine whether thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulmert, David, Cronin, Angel M, Björk, Thomas, O'Brien, Matthew F, Scardino, Peter T, Eastham, James A, Becker, Charlotte, Berglund, Göran, Vickers, Andrew J, Lilja, Hans
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275744/
https://www.ncbi.nlm.nih.gov/pubmed/18279502
http://dx.doi.org/10.1186/1741-7015-6-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275744/
https://www.ncbi.nlm.nih.gov/pubmed/18279502
http://dx.doi.org/10.1186/1741-7015-6-6

Ejemplares similares